Prognostic value and microenvironmental crosstalk of exosome-related signatures in human epidermal growth factor receptor 2 positive breast cancer

被引:0
|
作者
Zhao, Ji [5 ]
Shen, Feng [6 ]
Hu, Yue-Mei [7 ]
Yin, Kai [5 ]
Chen, Ying [1 ]
Chen, Yan-Jie [2 ,3 ]
Hu, Qun-Chao [1 ]
Liang, Li [4 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Tong Ren Hosp, Dept Radiat Oncol, 1111 Xianxia Rd, Shanghai 200336, Peoples R China
[2] Fudan Univ, Zhongshan Hosp Xiamen, Dept Gastroenterol, 668 Jinhu Rd, Xiamen, Peoples R China
[3] Fudan Univ, Zhongshan Hosp, Dept Gastroenterol, 180 Fenglin Rd, Shanghai 200032, Peoples R China
[4] Fudan Univ, Zhongshan Hosp, Dept Med Oncol, 180 Fenglin Rd, Shanghai 200032, Peoples R China
[5] Shanghai Jiao Tong Univ, Tong Ren Hosp, Sch Med, Dept Breast Surg, Shanghai 200336, Peoples R China
[6] Fudan Univ, Zhongshan Hosp Xiamen, Dept Med Oncol, Xiamen 361015, Peoples R China
[7] Shanghai Jiao Tong Univ, Sch Med, Tong Ren Hosp, Dept Pathol, Shanghai 200336, Peoples R China
来源
OPEN LIFE SCIENCES | 2024年 / 19卷 / 01期
基金
上海市自然科学基金; 中国国家自然科学基金;
关键词
breast cancer; exosomes; human epithelial growth factor receptor 2; microenvironment; prognosis; biomarkers; SINGLE-CELL; STATISTICS; EXPRESSION; ATLAS;
D O I
10.1515/biol-2022-0899
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
This study aimed to determine the prognostic value and microenvironmental crosstalk of exosome-related signatures in human epidermal growth factor receptor 2 positive breast cancer (HER2+ BC). Transcriptome sequencing and clinicopathological data were downloaded from the Cancer Genome Atlas. The 10X single cell sequencing dataset was downloaded from the National Center for Biotechnology Information Gene Expression Omnibus. Exosomes-Related Genes were extracted from the ExoCarta and Gene Set Enrichment Analysis databases. FGF9, SF3B4, and EPCAM were found and deemed the most accurate predictive signatures. Patients with HER2+ BC were subtyped into three groupings by exosome prognostic gene (EPGs). The expression of SF3B4 was positively linked with the infiltration of macrophages, neutrophils, and CD4+ T cells. The expression characteristics of EPGs were associated with the biological process of "response to xenobiotic stimuli." Interactions were relatively high between malignant epithelial cells and fibroblasts, endothelial cells, monocytes, and macrophages. Malignant epithelial cells interact more with fibroblasts and endothelial cells. The migration inhibitory factor pathway was the primary outgoing signaling pattern, while the C-C motif chemokine ligand pathway was the primary incoming signaling pattern for communication between malignant epithelial cells and macrophages. This study described the role of exosome signatures in the prognosis and microenvironment of HER2+ BC and provided a basis for future research.
引用
收藏
页数:20
相关论文
共 50 条
  • [41] Pertuzumab for the treatment of patients with human epidermal growth factor receptor 2-positive breast cancer in Japan
    Osako, Tomofumi
    Nishimura, Reiki
    Nishiyama, Yasuyuki
    Fujisue, Mamiko
    MOLECULAR AND CLINICAL ONCOLOGY, 2015, 3 (06) : 1268 - 1274
  • [42] FTY720 in resistant human epidermal growth factor receptor 2-positive breast cancer
    Wei-Pang Chung
    Wei-Lun Huang
    Wei-An Liao
    Chun-Hua Hung
    Chi-Wu Chiang
    Chun Hei Antonio Cheung
    Wu-Chou Su
    Scientific Reports, 12
  • [43] Management of Early-Stage Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
    Pernas, Sonia
    Tolaney, Sara M.
    JCO ONCOLOGY PRACTICE, 2021, 17 (06) : 320 - +
  • [44] Biomarkers for the identification of recurrence in human epidermal growth factor receptor 2-positive breast cancer patients
    Pruneri, Giancarlo
    Bonizzi, Giuseppina
    Vingiani, Andrea
    CURRENT OPINION IN ONCOLOGY, 2016, 28 (06) : 476 - 483
  • [45] Tailored duration of adjuvant trastuzumab for human epidermal growth factor receptor 2-positive breast cancer
    Yu, Ke-Da
    Wang, Xin
    Chen, Wan-Kun
    Fan, Lei
    Mo, Miao
    Chen, Han
    NPJ PRECISION ONCOLOGY, 2020, 4 (01)
  • [46] Pertuzumab for the treatment of human epidermal growth factor receptor type 2-positive metastatic breast cancer
    Chung, Clement
    Lam, Masha S. H.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2013, 70 (18) : 1579 - 1587
  • [47] Radiosensitizing effect of lapatinib in human epidermal growth factor receptor 2-positive breast cancer cells
    Yu, Tosol
    Cho, Bong Jun
    Choi, Eun Jung
    Park, Ji Min
    Kim, Dan Hyo
    Kim, In Ah
    ONCOTARGET, 2016, 7 (48) : 79075 - 79086
  • [48] FTY720 in resistant human epidermal growth factor receptor 2-positive breast cancer
    Chung, Wei-Pang
    Huang, Wei-Lun
    Liao, Wei-An
    Hung, Chun-Hua
    Chiang, Chi-Wu
    Cheung, Chun Hei Antonio
    Su, Wu-Chou
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [49] Tailored duration of adjuvant trastuzumab for human epidermal growth factor receptor 2-positive breast cancer
    Ke-Da Yu
    Xin Wang
    Wan-Kun Chen
    Lei Fan
    Miao Mo
    Han Chen
    npj Precision Oncology, 4
  • [50] Cost effectiveness of adjuvant trastuzumab in human epidermal growth factor receptor 2-positive breast cancer
    Liberato, Nicola Lucio
    Marchetti, Monia
    Barosi, Giovanni
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (06) : 625 - 633